Company
FranceGlaxoWellcome Production, Evreux, France – FDA Inspections
Inspection records and compliance data for GlaxoWellcome Production in Evreux. 5 FDA inspections on record, 1 Form 483, last inspected April 08, 2022.
Company Profile
This profile covers GlaxoWellcome Production based in Evreux, France.
FDA Inspection History
- FDA inspections
- 5
- OAI
- 0
- VAI
- 2
- NAI
- 3
- Form 483s
- 1
- Warning letters
- 0
First inspected March 19, 2009. Last inspected April 8, 2022.
Most cited issue areas
- Failure to meet specifications1 inspection
FDA inspections (5)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| April 8, 2022 | VAI | Human Drugs · Drug Quality Assurance | 1242271 |
| March 3, 2017 | VAI | Human Drugs · Drug Quality Assurance | 1005796 |
| April 11, 2014 | NAI | Human Drugs · Drug Quality Assurance | 886660 |
| February 27, 2012 | NAI | Human Drugs · Drug Quality Assurance | 772742 |
| March 19, 2009 | NAI | Human Drugs · Drug Quality Assurance | 572931 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
GlaxoWellcome Production
FEI Number
3002807436
Address
Zone Industrielle 2, 23 Rue Lavoisier, Evreux, France
Country
France
ID: f88b8738-02c0-496c-bdc6-4d9f893e1cb8